Main content

    Esophageal Cancer Clinical Trials

    CPMC Cancer Services

    Oncology / Cancer Clinical Trials Main Page | Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at ClinicalTrials.gov


    Active Trials

    Title: A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
    Description: This randomized phase II trial studies how well oxaliplatin, leucovorin calcium, and fluorouracil work compared to irinotecan hydrochloride and docetaxel in treating patients with esophageal cancer, gastric cancer, or gastroesophageal junction cancer.
    Investigator: NCI - National Cancer Institute
    Eligibility: Subjects, 18 y/o and older, who have unresectable advanced or metastatic histologically or cytologically confirmed adenocarcinoma of the esophagus, stomach, or gastroesophageal junction (GEJ)
    Status: Please contact site for study status
    Contact: Peter Gasper, 415-600-3472, Email: GasperP@cpmcri.org about Study SWOG 1201

    Title: A Phase III Trial Evaluating The Addition Of Trastuzumab To Trimodality Treatment Of Her2-Overexpressing Esophageal Adenocarcinoma
    Description: Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Investigator: NCI - National Cancer Institute
    Eligibility: Subjects, 18 y/o and older, who have pathologically confirmed primary adenocarcinoma of the esophagus, distal, or esophagogastric junction
    Status: Please contact site for study status
    Contact: Peter Gasper, 415-600-3472, Email: GasperP@cpmcri.org about Study RTOG 1010

    • updated October 2014

    Back to top